All
Dr Lucio Gordan Discusses Cost Differentials, Survivorship Care in Oncology
March 10th 2020There has been significant improvement in payers' understanding of site of care issues, but steps still need to be taken to address these issues, said Lucio Gordan, MD, president and managing physician at Florida Cancer Specialists.
Read More
A Frank Discussion About Implementing the OCM in Everyday Practice
December 5th 2019In today’s Managed Care Cast, we bring you portions of the panel discussion during the the last Institute for Value-Based Medicine® (IVBM®) event for 2019, where oncologists and others shared their thoughts, successes, and frustrations with the current Oncology Care Model, as well as the question and answer session.
Read More
Dr Richard Snyder Offers Key Features of Value-Based Agreements
December 4th 2019Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses key features that payers should include when implementing a value-based agreement.
Read More
NAACOS: ACOs Saved Medicare $3.5 Billion From 2013 to 2017
December 4th 2019Accountable care organizations (ACOs) have saved Medicare a total of $3.53 billion from 2013 to 2017, or $755 million after shared savings were paid out, according to a new report from the National Association of ACOs (NAACOS).
Read More
Dr Richard Snyder Discusses the Role of Data in Value-Based Agreements
November 23rd 2019Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses the role of data exchange and analytics in value-based agreements.
Read More
Dr Richard Snyder Emphasizes the Importance of Care Coordination in Value-Based Contracting
November 10th 2019Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.
Read More
Value Considerations Should Begin Very Early in the New Drug Development Life Cycle
October 31st 2019Value needs to be considered early in the development life cycle of a therapy and should be continued throughout, even into the postlaunch space using real-world studies, according to a presentation on value-based services and their life cycles at the AMCP Nexus 2019 meeting.
Read More
Dr Richard Snyder: How Value-Based Agreements Can Benefit All Stakeholders
October 27th 2019Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, explains how value-based agreements can benefit providers, patients, and payers.
Read More
Dr Richard Snyder on the Impact of Novel, Costly Drugs on Prevalence of Value-Based Agreements
October 15th 2019Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses how the increasing share of novel, costly therapies will impact the prevalence of value-based agreements.
Read More
HHS Releases Proposal to Reform Stark Law, Antikickback Rules
October 9th 2019In a long-awaited move, HHS announced Tuesday plans to reform federal antikickback statutes and overhaul the so-called Stark Law, which was originally intended as a safeguard against financial incentives that would inappropriately influence physicians’ clinical decisions, in an effort to speed the transition to value-based care.
Read More
Dr Lawrence Shulman Discusses the Role of Rising Drug Costs in Value-Based Care
October 6th 2019Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania, explains how providers are reacting to more effective, more costly therapies entering the cancer landscape.
Read More
Terrill Jordan Discusses OCM Performance Period 4 Results
October 1st 2019Terrill Jordan, chief executive officer of Regional Cancer Care Associates, discusses Oncology Care Model performance period 4 results and the biggest challenges community oncologists continue to face when trying to perform under the model.
Read More
Defining, Standardizing, and Acting on Patient-Reported Outcomes in Cancer Care
September 27th 2019During a panel discussion on defining, standardizing, and reporting quality in cancer care during the National Comprehensive Cancer Network Policy Summit held September 12 in Washington, DC, it became clear that stakeholders of all backgrounds have set their focus on one type of metric in particular: patient-reported outcomes.
Read More
Facilitating the Qualitative Improvement of Oncology Through Value-Based Care
September 27th 2019Coverage of the first half of the Institute for Value-Based Medicine® (IVBM®) session held September 19, 2019, in Philadelphia, Pennsylvania. IVBM® is an initiative of The American Journal of Managed Care®.
Read More
Dissecting OCM Performance Period 4 Results and Their Implications
September 25th 2019With Oncology Care Model performance period 4 results out now, it’s a transformative point in the model in which practices that have not yet achieved a performance-based payment have to either enter 2-sided risk or leave the model. To dive into the most recent results and their implications, we spoke with Charles Saunders, MD, chief executive officer of Integra Connect.
Read More
Dr Blase Polite Outlines the Decision to Move to 2-Sided Risk in the OCM
September 22nd 2019CMS is trying to make a 2-sided risk model in the Oncology Care Model enticing for practices, but there is still a lot of math practices need to work out before making the decision, said Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago.
Read More
Lani Alison Discusses How the OCM Allowed for Better Integration of Palliative Care
September 15th 2019Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains how the implementation of the Oncology Care Model (OCM) allowed practices to better integrate palliative care.
Read More
Examining Physician-Initiated Alternative Payment Models, a New Wave of Payment Reform
September 12th 2019To date, most alternative payment models (APMs) that have emerged in the shift toward value-based care have been initiated by payers and focused on primary care providers. However, there has recently been a new wave of payment reform in which providers, mostly specialists, are designing and implementing their own APMs in their practices. A study published in the September issue of The American Journal of Managed Care® analyzed some of these new payment models to gain insight into what providers are prioritizing in their APMs.
Read More
Lani Alison Outlines Questions Patients Have About Care Pathways, Treatment Guidelines
September 5th 2019Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, explains the questions that patients have about oncology care pathways and treatment guidelines.
Read More
Lani Alison: How Providers Discuss the OCM With Patients
August 18th 2019Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates, discusses how providers discuss the Oncology Care Model (OCM) with patients and the questions they ask about it.
Read More
How Are Oncology Practices Communicating Value-Based Care to Employers and Patients?
August 14th 2019On this episode of Managed Care Cast, we’re bringing you a portion of a panel discussion about the Oncology Care Model, held in July 2019 during a meeting of The Institute for Value-Based Medicine® (IVBM), an initiative of The American Journal of Managed Care®. At IVBM events, we gather thought leaders to share best practices across medicine, pharmacy, and management in regional locations around the country. This podcast is taken from our meeting focusing on Innovation and Quality in Oncology Care.
Read More
KOL Corner: Amy Ellis Discusses Viewing Value-Based Care as a Culture With Jeff Hunnicutt
August 8th 2019Transitioning to value-based care is a marathon, not a race, and should be viewed as a mission and a culture, Jeff Hunnicutt, chief executive officer at Highlands Oncology Group, told Amy Ellis, director of quality and value-based care at Northwest Medical Specialties. In order to successfully transform a practice, there needs to be a clear message and set values ingrained in the mindset of staff at the frontline of patient care.
Read More